These results show that nesfatin-1 plays an important role in the body’s metabolic control mechanisms and can be used as a potential therapeutic agent in metabolic disorders, especially in HT patients having overweight [21], [22], [23]. The gene discussed is NUCB2; the disease is metabolic disease.